170 related articles for article (PubMed ID: 34845932)
1. Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts.
Tikkanen E; Jägerroos V; Holmes MV; Sattar N; Ala-Korpela M; Jousilahti P; Lundqvist A; Perola M; Salomaa V; Würtz P
J Am Heart Assoc; 2021 Dec; 10(23):e021995. PubMed ID: 34845932
[TBL] [Abstract][Full Text] [Related]
2. Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.
Levin MG; Zuber V; Walker VM; Klarin D; Lynch J; Malik R; Aday AW; Bottolo L; Pradhan AD; Dichgans M; Chang KM; Rader DJ; Tsao PS; Voight BF; Gill D; Burgess S; Damrauer SM
Circulation; 2021 Aug; 144(5):353-364. PubMed ID: 34139859
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study.
Gurdasani D; Sjouke B; Tsimikas S; Hovingh GK; Luben RN; Wainwright NW; Pomilla C; Wareham NJ; Khaw KT; Boekholdt SM; Sandhu MS
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3058-65. PubMed ID: 23065826
[TBL] [Abstract][Full Text] [Related]
5. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
Grenon SM; Vittinghoff E; Owens CD; Conte MS; Whooley M; Cohen BE
Vasc Med; 2013 Aug; 18(4):176-84. PubMed ID: 23835937
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
[TBL] [Abstract][Full Text] [Related]
7. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.
Würtz P; Havulinna AS; Soininen P; Tynkkynen T; Prieto-Merino D; Tillin T; Ghorbani A; Artati A; Wang Q; Tiainen M; Kangas AJ; Kettunen J; Kaikkonen J; Mikkilä V; Jula A; Kähönen M; Lehtimäki T; Lawlor DA; Gaunt TR; Hughes AD; Sattar N; Illig T; Adamski J; Wang TJ; Perola M; Ripatti S; Vasan RS; Raitakari OT; Gerszten RE; Casas JP; Chaturvedi N; Ala-Korpela M; Salomaa V
Circulation; 2015 Mar; 131(9):774-85. PubMed ID: 25573147
[TBL] [Abstract][Full Text] [Related]
8. Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations.
Deng K; Pan XF; Voehler MW; Cai Q; Cai H; Shu XO; Gupta DK; Lipworth L; Zheng W; Yu D
J Am Heart Assoc; 2024 May; 13(10):e034364. PubMed ID: 38726919
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
van Capelleveen JC; Bernelot Moens SJ; Yang X; Kastelein JJP; Wareham NJ; Zwinderman AH; Stroes ESG; Witztum JL; Hovingh GK; Khaw KT; Boekholdt SM; Tsimikas S
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1206-1212. PubMed ID: 28473441
[TBL] [Abstract][Full Text] [Related]
10. Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis - Is there a difference?
Leiherer A; Mündlein A; Brandtner EM; Säly CH; Ramadani H; Vonbank A; Mader A; Dopheide JF; Jylhä A; Lääperi M; Laaksonen R; März W; Fraunberger P; Kleber M; Drexel H
J Intern Med; 2021 Dec; 290(6):1249-1263. PubMed ID: 34337800
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015.
Sundaram V; Bloom C; Zakeri R; Halcox J; Cohen A; Bowrin K; Briere JB; Banerjee A; Simon DI; Cleland JGF; Rajagopalan S; Quint JK
Eur Heart J; 2020 May; 41(17):1636-1649. PubMed ID: 31883328
[TBL] [Abstract][Full Text] [Related]
12. Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease.
Smolderen KG; Mena-Hurtado C; Eikelboom JW; Bosch J; Xie F; Ramasundarahettige C; Bhatt DL; Anand SS
Eur J Prev Cardiol; 2023 May; 30(7):535-545. PubMed ID: 36444513
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A
Garg PK; Norby FL; Polfus LM; Boerwinkle E; Gibbs RA; Grove ML; Folsom AR; Garimella PS; Matsushita K; Hoogeveen RC; Ballantyne CM
Atherosclerosis; 2018 Jan; 268():12-18. PubMed ID: 29169030
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.
van Wijk DF; Boekholdt SM; Wareham NJ; Ahmadi-Abhari S; Kastelein JJ; Stroes ES; Khaw KT
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2888-94. PubMed ID: 24072695
[TBL] [Abstract][Full Text] [Related]
16. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
[TBL] [Abstract][Full Text] [Related]
17. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.
Natarajan P; Collier TS; Jin Z; Lyass A; Li Y; Ibrahim NE; Mukai R; McCarthy CP; Massaro JM; D'Agostino RB; Gaggin HK; Bystrom C; Penn MS; Januzzi JL
J Am Coll Cardiol; 2019 May; 73(17):2135-2145. PubMed ID: 31047001
[TBL] [Abstract][Full Text] [Related]
18. Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease.
Volis I; Saliba W; Jaffe R; Eitan A; Zafrir B
Am J Cardiol; 2020 Aug; 128():28-34. PubMed ID: 32650921
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
